Arcturus Therapeutics Holdings Inc. (the "Company", "Arcturus", Nasdaq: ARCT), a commercial messenger RNA medicines company ...

NIH Director Jay Bhattacharya offered an explanation for the cancellation of mRNA vaccine contracts that didn't align with ...

W hen BioNTech agreed to acquire rival messenger RNA company CureVac in a $1.25 billion stock deal earlier this summer, some ...

Researchers have launched HTGAnalyzer, a new, easy-to-use, fast and reproducible bioinformatics tool for advanced ...

Market opportunities for mRNA synthesis raw materials lie in the growing demand for high-purity materials driven by mRNA therapeutics. Key drivers include advancements in mRNA technology, regulatory ...

CDC employees were given the option to work from home on Monday following the shooting that targeted the agency’s ...

"People are going to die because we're cutting short funding for this technology," Dr. Jerome Adams said in an interview with ...

THESE WERE JUST THREE of the specious claims Kennedy made; there were others, too. But it’s likely that for many people who ...

CDC employees across all of the agency’s campuses will be teleworking today, after a gunman shot multiple rounds into four ...

The Barcelona Institute for Global Health (ISGlobal), a centre supported by the "la Caixa" Foundation, has launched ...

CureVac ( (CVAC)) has provided an announcement. On August 7, 2025, CureVac announced the resolution of U.S. patent litigation with Pfizer/BioNTech concerning mRNA-based COVID-19 vaccines. As part of ...

Q: I have Type 2 diabetes, and my doctor insists that I give up beverages with almost all sugar substitutes and stick with water. Can you explain what’s wrong with ...